UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Associations between gender and health‐related quality of life in people with IgE‐mediated food allergy and their caregivers: A systematic review

Clinical and experimental allergy, 2024-02, Vol.54 (2), p.93-108

2024

Volltextzugriff (PDF)

Two‐year post‐treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy‐003 Long‐Term (PPOIT‐003LT) study

Allergy (Copenhagen), 2024-10, Vol.79 (10), p.2759-2774

2024

Volltextzugriff (PDF)

Longitudinal peanut and Ara h 2 specific‐IgE, ‐IgG4, and ‐IgG4/‐IgE ratios are associated with the natural resolution of peanut allergy in childhood

Allergy (Copenhagen), 2024-07, Vol.79 (7), p.1868-1880

2024

Volltextzugriff (PDF)

Cost-effectiveness analysis of probiotic peanut oral immunotherapy (PPOIT) versus placebo in Australian children with peanut allergy alongside a randomised trial

BMJ open, 2023-12, Vol.13 (12), p.e075521-e075521

2023

Volltextzugriff (PDF)

Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement

Clinical and experimental allergy, 2022-06, Vol.52 (6), p.806-811

2022

Volltextzugriff (PDF)

TreEAT trial: Protocol for a randomized controlled trial investigating the efficacy and safety of early introduction of tree nuts for the prevention of tree nut allergy in infants with peanut allergy

Pediatric allergy and immunology, 2023-03, Vol.34 (3), p.e13930-n/a

2023

Volltextzugriff (PDF)

The Efficacy and Safety of Probiotic and Peanut Oral Immunotherapy for inducing Desensitization and Sustained Unresponsiveness: Results from a Phase 2b Multi-center Randomized Trial (PPOIT-003)

Journal of allergy and clinical immunology, 2020-02, Vol.145 (2), p.AB335

2020

Volltextzugriff (PDF)

Statewide prevalence of school children at risk of anaphylaxis and rate of adrenaline autoinjector activation in Victorian government schools, Australia

Journal of allergy and clinical immunology, 2016-08, Vol.138 (2), p.529-535

2016

Volltextzugriff (PDF)

Study protocol of a phase 2, dual-centre, randomised, controlled trial evaluating the effectiveness of probiotic and egg oral immunotherapy at inducing desensitisation or sustained unresponsiveness (remission) in participants with egg allergy compared with placebo (Probiotic Egg Allergen Oral Immunotherapy for Treatment of Egg Allergy: PEAT study)

BMJ open, 2021-07, Vol.11 (7), p.e044331-e044331

2021

Volltextzugriff (PDF)

Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)

BMJ open, 2020-09, Vol.10 (9), p.e035871-e035871

2020

Volltextzugriff (PDF)

Reactions to Peanut during a Double-Blind Placebo Controlled Food Challenge (DBPCFC) for Enrolment in a Randomized Trial

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB405-AB405

2018

Volltextzugriff (PDF)

Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12–17-year olds in Victoria, Australia

BMJ paediatrics open, 2022-06, Vol.6 (1), p.e001472

2022

Volltextzugriff (PDF)

Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy in children with peanut allergy

Clinical and experimental allergy, 2022-06, Vol.52 (6), p.735-746

2022

Volltextzugriff (PDF)

Longitudinal peanut and Ara h 2 specific-IgE, -IgG4 and -IgG4/-IgE ratios are associated with the natural resolution of peanut allergy in childhood

Journal of allergy and clinical immunology, 2024-02, Vol.153 (2), p.AB33

2024

Volltextzugriff (PDF)

The importance of long-term follow-up of oral immunotherapy in food allergy

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2024-07, Vol.12 (7), p.1945-1946

2024

Volltextzugriff (PDF)

Peanut Oral Immunotherapy

Immunology and allergy clinics of North America, 2020-02, Vol.40 (1), p.97-110

2020

Volltextzugriff (PDF)

Peanut Oral Immunotherapy: State of the Art

Immunology and allergy clinics of North America, 2020-02, Vol.40 (1), p.97-110

2020

Volltextzugriff (PDF)

Food Allergen Immunotherapy in Preschool Children: Do We Have the Evidence?

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-04, Vol.11 (4), p.1028-1035

2023

Volltextzugriff (PDF)

Longitudinal peanut and Ara h 2 specific-IgE, -IgG 4 , and -IgG 4 /-IgE ratios are associated with the natural resolution of peanut allergy in childhood

Allergy (Copenhagen), 2024-07, Vol.79 (7), p.1868-1880

2024

Volltextzugriff (PDF)

Health-related quality of life outcomes in a Phase 2b Randomized Trial evaluating the effectiveness and safety of Probiotic Peanut Oral Immunotherapy

Journal of allergy and clinical immunology, 2022-02, Vol.149 (2), p.AB317-AB317

2022

Volltextzugriff (PDF)

Inborn Errors of Immunity in Children With Invasive Pneumococcal Disease: A Multicenter Prospective Study

The Pediatric infectious disease journal, 2023-10, Vol.42 (10), p.908-913

2023

Volltextzugriff (PDF)

Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial

The lancet child & adolescent health, 2022-03, Vol.6 (3), p.171-184

2022

Volltextzugriff (PDF)

Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2024-04, Vol.12 (4), p.1019-1028.e2

2024

Volltextzugriff (PDF)

From pre to post-BMT: autoimmunity and vasculitis in wiskott-aldrich syndrome

Pathology, 2015, Vol.47, p.S39-S39

2015

Volltextzugriff (PDF)

Association of Reaction Symptoms and Eliciting Dose With Health-Related Quality of Life in Children With Peanut Allergy

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2023-10, Vol.11 (10), p.3195-3202.e4

2023

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(60)
Berichte
(1)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Immunology
(23)
Isopenicillin N Synthase
(19)
Site-Directed Mutagenesis
(18)
Allergy
(17)
Humans
(15)
Cephalosporium Acremonium
(13)
Child
(12)
Biochemistry & Molecular Biology
(11)
Biological And Medical Sciences
(11)
Fundamental And Applied Biological Sciences. Psychology
(11)
Microbiology
(11)
Oxidoreductases - Metabolism
(11)
Quality Of Life
(11)
Molecular Sequence Data
(10)
Cloning, Molecular
(9)
Immunotherapy
(9)
Male
(9)
Mutagenesis, Site-Directed
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Associations between gender and health‐related quality of life in people with IgE‐mediated food allergy and their caregivers: A systematic review

Two‐year post‐treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy‐003 Long‐Term (PPOIT‐003LT) study

Longitudinal peanut and Ara h 2 specific‐IgE, ‐IgG4, and ‐IgG4/‐IgE ratios are associated with the natural resolution of peanut allergy in childhood

Cost-effectiveness analysis of probiotic peanut oral immunotherapy (PPOIT) versus placebo in Australian children with peanut allergy alongside a randomised trial

Probiotic peanut oral immunotherapy is associated with long‐term persistence of 8‐week sustained unresponsiveness and long‐lasting quality‐of‐life improvement

TreEAT trial: Protocol for a randomized controlled trial investigating the efficacy and safety of early introduction of tree nuts for the prevention of tree nut allergy in infants with peanut allergy

The Efficacy and Safety of Probiotic and Peanut Oral Immunotherapy for inducing Desensitization and Sustained Unresponsiveness: Results from a Phase 2b Multi-center Randomized Trial (PPOIT-003)

Statewide prevalence of school children at risk of anaphylaxis and rate of adrenaline autoinjector activation in Victorian government schools, Australia

Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)

Reactions to Peanut during a Double-Blind Placebo Controlled Food Challenge (DBPCFC) for Enrolment in a Randomized Trial

Myocarditis and myopericarditis cases following COVID-19 mRNA vaccines administered to 12–17-year olds in Victoria, Australia

Longitudinal antibody responses to peanut following probiotic and peanut oral immunotherapy in children with peanut allergy

Longitudinal peanut and Ara h 2 specific-IgE, -IgG4 and -IgG4/-IgE ratios are associated with the natural resolution of peanut allergy in childhood

The importance of long-term follow-up of oral immunotherapy in food allergy

Peanut Oral Immunotherapy

Peanut Oral Immunotherapy: State of the Art

Food Allergen Immunotherapy in Preschool Children: Do We Have the Evidence?

Longitudinal peanut and Ara h 2 specific-IgE, -IgG 4 , and -IgG 4 /-IgE ratios are associated with the natural resolution of peanut allergy in childhood

Health-related quality of life outcomes in a Phase 2b Randomized Trial evaluating the effectiveness and safety of Probiotic Peanut Oral Immunotherapy

Inborn Errors of Immunity in Children With Invasive Pneumococcal Disease: A Multicenter Prospective Study

Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial

Interaction Between Baseline Participant Factors and Treatment Effects Following Peanut Oral Immunotherapy

From pre to post-BMT: autoimmunity and vasculitis in wiskott-aldrich syndrome

Association of Reaction Symptoms and Eliciting Dose With Health-Related Quality of Life in Children With Peanut Allergy

Suchergebnisse filtern